ORBIMED ADVISORS LLC purchased 5M shares of ADICET BIO, INC. on the open market
Open‑market purchase worth $5.00M. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/10/2025ACC: 0000947871-25-000898
Director10% Owner
Since Sep 2020
+5M
Net shares
Net buyer
$5.00M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5M acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.50M
Price / share
$1.00
Trade value
$1.50M
% of position
19.9%
10/8/2025
7.53M→9.03M
Common Stock
Indirect
Shares
+3.50M
Price / share
$1.00
Trade value
$3.50M
% of position
353.4%
10/8/2025
990.25K→4.49M
Total
Net shares
+5M
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/8/2025 | P · Purchase | +1.50M | $1.00 | $1.50M | 19.9% | 7.53M | 9.03M |
| Common Stock Indirect | 10/8/2025 | P · Purchase | +3.50M | $1.00 | $3.50M | 353.4% | 990.25K | 4.49M |
| Total | +5M | $5M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned1.03M
Common Stock
IndirectShares owned1.26M
Common Stock
IndirectShares owned646.66K
Total
2.93M indirect2.93M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.03M | Indirect |
| Common Stock | 1.26M | Indirect |
| Common Stock | 646.66K | Indirect |
| Total | 2.93M | 2.93M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported